In the Guardian newspaper, UK physician and writer Margaret McCartney wrote, “Private health screening tests are oversold and under-explained: Health screening can cause more harm than it prevents, so companies have a duty to provide full information to customers.”
In the article, she introduced a new website called PrivateHealthScreening.org. She writes that:
“…out of frustration and anger, myself and a few colleagues — including GPs and neurologists — have set up a website, www.privatehealthscreening.org to share information about screening and suggest things that people who are considering private tests might want to think about first. One of our collaborators is emeritus professor of neurology Charles Warlow, who went for a Life Line Screening in his local church call and concluded, in the BMJ, “Why is this nonsense tolerated or allowed?”
It’s a good question and one that UK regulators seem not to be asking.”
Screenshot of the new site’s masthead:
The site includes examples of “misleading advertisements.”
And it lists links to an “Evidence Bank” for the following screening tests:
Screening the carotid artery
http://www.uspreventiveservicestaskforce.org/uspstf/uspsacas.htm
http://www.ahrq.gov/downloads/pub/prevent/pdfser/cas/cases.pdf
http://www.screening.nhs.uk/private-screeningECG screening
http://annals.org/article.aspx?volume=155&page=375
http://www.screening.nhs.uk/private-screeningProstate cancer screening
jama.ama-assn.org/content/305/22/2295.long
www.nejm.org/doi/full/10.1056/NEJMoa0810696
jnci.oxfordjournals.org/content/101/6/362.longGenetic screening
Osteoporosis
http://www.screening.nhs.uk/osteoporosis
http://www.bmj.com/content/344/bmj.e3502.full?ijkey=tzRK2ncLto2JJ9I&keytype=refLiver function tests
www.springerlink.com/content/x6kvhu744u700103/
Brain scans – incidental findings in the population and aneurysms
www.nejm.org/doi/full/10.1056/NEJMoa070972
www.nejm.org/doi/full/10.1056/NEJM199812103392401
This is a very important contribution to the public dialogue about screening tests – and about the tradeoffs of potential benefits and potential harms.
Opinions on other issues in news, journals, PR, advertising, marketing
Many of the principles that we promoted to journalists and to the general public from 2006-18 are embodied in this terrific project based in Oslo. https://t.co/KO1o9JTYK7
Following a shift in journalism’s business model, a diverse ecosystem of publications, many covering science, has sprung up online. This has made it more difficult to sort out what qualifies as journalism, what doesn’t, and whether the public even cares.
https://t.co/qO2a27FiSe
Researchers and journalists do the public a grave disservice when they spin health study results to make them appear safer or more effective than warranted, says @HealthNewsRevu founder @garyschwitzer https://t.co/QIKsRbP6Ed
Comments (6)
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Joelle Reizes
October 18, 2012 at 4:03 pmWhile we understand there will always be debates about health screenings, Life Line Screening will continue to offer high quality, convenient, affordable private screenings that individuals can voluntarily choose if they have appropriate risk factors and decide that the screenings are right for them. Recent criticism of private health screenings fails to account for the context in which screenings are taking place. Others are free to disagree, but we believe a model that promotes education and prevention can serve a vital role in the health care continuum. Please visit our blog for more facts about health screenings and to read our full response to recent critiques: http://www.lifelinescreeningblog.com/index.php/presenting-the-facts-by-addressing-margaret-mccartneys-issues-against-life-line-screening/
Joelle Reizes
Communications Director at Life Line Screening
Gary Schwitzer
October 18, 2012 at 5:37 pmJoelle,
We will publish your comment, even though our comments policy clearly states that I will delete any comment “with any kind of product pitch” – which is how some might interpret your comment. But we will publish it because your link is a response to Dr. McCartney’s writings.
But I’m curious: did you comment about Dr. McCartney’s article in the newspaper or on the website of The Guardian where it was originally published?
Joelle Reizes
October 18, 2012 at 4:03 pmWhile we understand there will always be debates about health screenings, Life Line Screening will continue to offer high quality, convenient, affordable private screenings that individuals can voluntarily choose if they have appropriate risk factors and decide that the screenings are right for them. Recent criticism of private health screenings fails to account for the context in which screenings are taking place. Others are free to disagree, but we believe a model that promotes education and prevention can serve a vital role in the health care continuum. Please visit our blog for more facts about health screenings and to read our full response to recent critiques: http://www.lifelinescreeningblog.com/index.php/presenting-the-facts-by-addressing-margaret-mccartneys-issues-against-life-line-screening/
Joelle Reizes
Communications Director at Life Line Screening
Gary Schwitzer
October 18, 2012 at 5:37 pmJoelle,
We will publish your comment, even though our comments policy clearly states that I will delete any comment “with any kind of product pitch” – which is how some might interpret your comment. But we will publish it because your link is a response to Dr. McCartney’s writings.
But I’m curious: did you comment about Dr. McCartney’s article in the newspaper or on the website of The Guardian where it was originally published?
mgt mccartney
October 19, 2012 at 6:19 pmI’ve posted this on the lifeline screening blog.
Dear Joelle
Sadly your response does not actually address the issue, which is that people have been advertised to by your company through making false promises of the benefits of your tests. Screening is usually complex and always contains a balance of pros and cons. You have not informed people about the drawbacks, uncertainties, hazards or lack of evidence for what you offer. This is the real problem and one that you haven’t addressed. Your new UK adverts are a slight improvement in that they don’t make some unproven claims as before, but still do not explain the downsides of screening.
Your comments about me then effectively suggesting that I have told people to just go on ‘waiting for symptoms’ simply doesn’t reflect the evidence or indeed what I have said. People can do many things to reduce their risk of many diseases. Most of this advice is straightforward. Eat a varied diet, don’t be over or underweight, exercise daily, don’t smoke, drink moderately, do work you enjoy, see friends and meet people. My comments do however reflect the fact that screening tests can lead to harm through unnecessary interventions. The less chance of benefit, then the greater risk of unnecessary harm.
The study you cite (4) above, was a complex long term intervention examining many types of cardiovascular risk factors, in particular BP treatment. It is not possible to attribute any potential benefit (and there may have been problems with this trial in that the effect may not have been down to the activities done because of the trial, see the discussion section) to the activities of Lifeline Screening based on this.
Next, customer testimonials do not count as evidence. We know that harmed people tend to report fewer adverse outcomes because of the ‘popularity paradox’ – people tend to feel grateful that a false positive was a false positive rather than feeling angry that they were unnecessarily tested for something that wasn’t going to harm them. Also, seriously harmed patients can’t always speak up for themselves either. Testimonials are not reliable evidence.
You also say that “No screening is without risk, and any screening has a small, but certain risk of adverse outcomes as have any medicines or surgeries. On the basis of probabilities, however, its advantages far outweigh potential risks.” That’s really pretty incredible, given the huge amount of research that has been done on screening, and the many findings of ineffective screening tests – that did too much harm to make the benefits worthwhile. And in any case, it should be up to the person to decide what level of risk is acceptable to them – not for a commercial company to make that value judgement for them.
Why don’t you read the extensive evidence about the balance of benefit and harms that we have on our website?
http://privatehealthscreen.org/evidencebank.html
There is no reason to think that knowledge and prevention of disease has to include non evidence based screening tests, and the arguments you are using are similar to those that people who promote homeopathy use.
I’d like you to consider what informed choice really means and whether or not your customers are being given fair and unbiased information before handing over their money.
mgt mccartney
October 19, 2012 at 6:19 pmI’ve posted this on the lifeline screening blog.
Dear Joelle
Sadly your response does not actually address the issue, which is that people have been advertised to by your company through making false promises of the benefits of your tests. Screening is usually complex and always contains a balance of pros and cons. You have not informed people about the drawbacks, uncertainties, hazards or lack of evidence for what you offer. This is the real problem and one that you haven’t addressed. Your new UK adverts are a slight improvement in that they don’t make some unproven claims as before, but still do not explain the downsides of screening.
Your comments about me then effectively suggesting that I have told people to just go on ‘waiting for symptoms’ simply doesn’t reflect the evidence or indeed what I have said. People can do many things to reduce their risk of many diseases. Most of this advice is straightforward. Eat a varied diet, don’t be over or underweight, exercise daily, don’t smoke, drink moderately, do work you enjoy, see friends and meet people. My comments do however reflect the fact that screening tests can lead to harm through unnecessary interventions. The less chance of benefit, then the greater risk of unnecessary harm.
The study you cite (4) above, was a complex long term intervention examining many types of cardiovascular risk factors, in particular BP treatment. It is not possible to attribute any potential benefit (and there may have been problems with this trial in that the effect may not have been down to the activities done because of the trial, see the discussion section) to the activities of Lifeline Screening based on this.
Next, customer testimonials do not count as evidence. We know that harmed people tend to report fewer adverse outcomes because of the ‘popularity paradox’ – people tend to feel grateful that a false positive was a false positive rather than feeling angry that they were unnecessarily tested for something that wasn’t going to harm them. Also, seriously harmed patients can’t always speak up for themselves either. Testimonials are not reliable evidence.
You also say that “No screening is without risk, and any screening has a small, but certain risk of adverse outcomes as have any medicines or surgeries. On the basis of probabilities, however, its advantages far outweigh potential risks.” That’s really pretty incredible, given the huge amount of research that has been done on screening, and the many findings of ineffective screening tests – that did too much harm to make the benefits worthwhile. And in any case, it should be up to the person to decide what level of risk is acceptable to them – not for a commercial company to make that value judgement for them.
Why don’t you read the extensive evidence about the balance of benefit and harms that we have on our website?
http://privatehealthscreen.org/evidencebank.html
There is no reason to think that knowledge and prevention of disease has to include non evidence based screening tests, and the arguments you are using are similar to those that people who promote homeopathy use.
I’d like you to consider what informed choice really means and whether or not your customers are being given fair and unbiased information before handing over their money.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like